Kensei Taguchi

990 total citations
38 papers, 680 citations indexed

About

Kensei Taguchi is a scholar working on Nephrology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Kensei Taguchi has authored 38 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 11 papers in Clinical Biochemistry and 9 papers in Molecular Biology. Recurrent topics in Kensei Taguchi's work include Chronic Kidney Disease and Diabetes (7 papers), Advanced Glycation End Products research (7 papers) and Renal Diseases and Glomerulopathies (5 papers). Kensei Taguchi is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Advanced Glycation End Products research (7 papers) and Renal Diseases and Glomerulopathies (5 papers). Kensei Taguchi collaborates with scholars based in Japan, United States and France. Kensei Taguchi's co-authors include Kei Fukami, Craig R. Brooks, Sho‐ichi Yamagishi, Bertha C. Elias, Seiya Okuda, Seiji Kishi, Joseph V. Bonventre, Takaharu Ichimura, Yusuke Kaida and Guillaume Canaud and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Scientific Reports.

In The Last Decade

Kensei Taguchi

31 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kensei Taguchi Japan 15 253 217 150 93 86 38 680
Fabio Gianiorio Italy 9 220 0.9× 211 1.0× 95 0.6× 156 1.7× 94 1.1× 10 706
May M. Rabadi United States 15 296 1.2× 209 1.0× 165 1.1× 79 0.8× 28 0.3× 20 818
Jun Feng China 18 363 1.4× 243 1.1× 80 0.5× 71 0.8× 36 0.4× 24 716
Maki Murakoshi Japan 18 218 0.9× 369 1.7× 145 1.0× 135 1.5× 223 2.6× 55 905
Kerstin Ebefors Sweden 17 282 1.1× 509 2.3× 70 0.5× 95 1.0× 48 0.6× 35 912
Tomohito Doke United States 16 427 1.7× 328 1.5× 59 0.4× 93 1.0× 111 1.3× 24 937
Mi Bai China 17 531 2.1× 361 1.7× 77 0.5× 65 0.7× 70 0.8× 40 1.0k
Nobuyuki Kajiwara Japan 9 236 0.9× 244 1.1× 93 0.6× 64 0.7× 88 1.0× 21 610
Xiaogang Du China 16 245 1.0× 204 0.9× 57 0.4× 88 0.9× 69 0.8× 44 791
Yusuke Sakamaki Japan 14 409 1.6× 312 1.4× 69 0.5× 139 1.5× 95 1.1× 23 972

Countries citing papers authored by Kensei Taguchi

Since Specialization
Citations

This map shows the geographic impact of Kensei Taguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensei Taguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensei Taguchi more than expected).

Fields of papers citing papers by Kensei Taguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensei Taguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensei Taguchi. The network helps show where Kensei Taguchi may publish in the future.

Co-authorship network of co-authors of Kensei Taguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Kensei Taguchi. A scholar is included among the top collaborators of Kensei Taguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensei Taguchi. Kensei Taguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taguchi, Kensei, et al.. (2025). Glucagon like peptide-1 modulates urinary sodium excretion in diabetic kidney disease via ENaC activation. Scientific Reports. 15(1). 11486–11486. 2 indexed citations
3.
Taguchi, Kensei, et al.. (2024). Three Cases of Red Yeast Rice–Containing Supplement-Induced Acute Kidney Injury and Fanconi Syndrome. American Journal of Kidney Diseases. 85(4). 522–526. 5 indexed citations
4.
Sugahara, Sho, et al.. (2024). Promotion of Mitochondrial Recovery Prevents Proximal Tubular Cell Maladaptive Repair and AKI-to-CKD Transition. Journal of the American Society of Nephrology. 35(10S).
5.
Taguchi, Kensei, et al.. (2024). Nocardiosis in a Patient with Nephrotic Syndrome Treated with Glucocorticoids and Tacrolimus. Internal Medicine. 64(9). 1380–1387.
6.
Taguchi, Kensei, et al.. (2023). IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury. Kidney International. 105(1). 99–114. 17 indexed citations
7.
Taguchi, Kensei & Kei Fukami. (2023). RAGE signaling regulates the progression of diabetic complications. Frontiers in Pharmacology. 14. 1128872–1128872. 67 indexed citations
8.
Taguchi, Kensei, et al.. (2023). Encapsulating Peritoneal Sclerosis in a Patient Receiving Peritoneal Dialysis and Glucocorticoid Therapy. Internal Medicine. 62(21). 3203–3207.
9.
Taguchi, Kensei, Bertha C. Elias, Benjamin Freedman, et al.. (2022). Cyclin G1 induces maladaptive proximal tubule cell dedifferentiation and renal fibrosis through CDK5 activation. Journal of Clinical Investigation. 132(23). 30 indexed citations
10.
Fujii, Makiko, et al.. (2022). Glomerular Microangiopathy in a Patient With Takayasu Arteritis. Journal of the American Society of Nephrology. 33(11S). 490–491.
11.
Nishimura, Kenji, Kensei Taguchi, Seiji Kishi, et al.. (2021). Dual disruption of eNOS and ApoE gene accelerates kidney fibrosis and senescence after injury. Biochemical and Biophysical Research Communications. 556. 142–148. 8 indexed citations
12.
Ishii, Ken J., Hanako Kobayashi, Kensei Taguchi, et al.. (2020). Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease. Kidney International. 99(3). 657–670. 22 indexed citations
13.
Canaud, Guillaume, Craig R. Brooks, Seiji Kishi, et al.. (2019). Cyclin G1 and TASCC regulate kidney epithelial cell G 2 -M arrest and fibrotic maladaptive repair. Science Translational Medicine. 11(476). 105 indexed citations
14.
Lynch, Matthew, Mei Tran, Kenneth M. Ralto, et al.. (2019). TFEB-driven lysosomal biogenesis is pivotal for PGC1α-dependent renal stress resistance. JCI Insight. 4(8). 45 indexed citations
15.
Kishi, Seiji, Craig R. Brooks, Kensei Taguchi, et al.. (2019). Proximal tubule ATR regulates DNA repair to prevent maladaptive renal injury responses. Journal of Clinical Investigation. 129(11). 4797–4816. 88 indexed citations
16.
Taguchi, Kensei, Sho‐ichi Yamagishi, Miyuki Yokoro, et al.. (2018). RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice. Scientific Reports. 8(1). 2686–2686. 29 indexed citations
17.
Yamagishi, Sho‐ichi, Kensei Taguchi, Yusuke Kaida, et al.. (2016). Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring. Clinical and Experimental Nephrology. 20(6). 853–861. 21 indexed citations
18.
Yamagishi, Sho‐ichi, Kensei Taguchi, & Kei Fukami. (2016). DNA-aptamers raised against AGEs as a blocker of various aging-related disorders. Glycoconjugate Journal. 33(4). 683–690. 18 indexed citations
19.
Fukami, Kei, Kensei Taguchi, Sho‐ichi Yamagishi, & Seiya Okuda. (2014). Receptor for advanced glycation endproducts and progressive kidney disease. Current Opinion in Nephrology & Hypertension. 24(1). 54–60. 38 indexed citations
20.
Nakayama, Yosuke, Seiji Ueda, Sho‐ichi Yamagishi, et al.. (2013). Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury. Kidney International. 85(3). 570–578. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026